VIRTTU Biologics, a clinical stage oncolytic immunotherapeutic company developing SEPREHVIR, a tumor-targeted herpes simplex vector, is pleased to announce the presentation of a poster by a key...

CytomX Therapeutics (Nasdaq: CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, highlighted data during an investor event today that...

CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to innovative therapeutics addressing cancer and other unmet medical needs, announces a poster presentation by...

Huawei today introduced its cyber security Top 100 requirements that organizations should consider when assessing suppliers' capabilities to provide end-to-end cyber security. At the 26th...

Today at the American Heart Association (AHA) Scientific Sessions 2015, Boehringer Ingelheim Pharmaceuticals, Inc. announced two key milestones for the company's initiatives in advancing...